Back
AbbVie Vs. Genmab AS Industry Stock Comparison
Sell
42
ABBV
AbbVie
Last Price:
175.76
Seasonality Move:
3.38%
Sell
31
GNMSF
Genmab AS
Last Price:
224.00
Seasonality Move:
2.76%
Sell
42
AbbVie (ABBV)
is a Sell
Is AbbVie a Buy, Sell or Hold?
- The current AbbVie [ABBV] share price is $175.67. The Score for ABBV is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- ABBV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Genmab AS (GNMSF)
is a Sell
Is Genmab AS a Buy, Sell or Hold?
- The current Genmab AS [GNMSF] share price is $224.00. The Score for GNMSF is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- GNMSF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ABBV Stock Price Chart
GNMSF Stock Price Chart
ABBV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.48 | Sell |
Relative Strength Index (14 RSI): | 41.31 | Sell |
Chaikin Money Flow: | 768004 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (168.03 - 189.67) | Sell |
Bollinger Bands (100): | (179.22 - 198.2) | Sell |
GNMSF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.48 | Sell |
Relative Strength Index (14 RSI): | 53.2 | Buy |
Chaikin Money Flow: | 2562 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (206.5 - 225.26) | Buy |
Bollinger Bands (100): | (220.1 - 268.8) | Sell |
ABBV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 178.41 | Sell |
20-day SMA: | 174.69 | Buy |
50-day SMA: | 186.36 | Sell |
200-day SMA: | 178.99 | Sell |
8-day EMA: | 177.17 | Sell |
20-day EMA: | 178.85 | Sell |
50-day EMA: | 183.32 | Sell |
200-day EMA: | 178.61 | Sell |
GNMSF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 217.33 | Buy |
20-day SMA: | 213.3 | Buy |
50-day SMA: | 222.75 | Buy |
200-day SMA: | 262.84 | Sell |
8-day EMA: | 217.07 | Buy |
20-day EMA: | 216.31 | Buy |
50-day EMA: | 224.71 | Sell |
200-day EMA: | 259.79 | Sell |
AbbVie Earnings Growth & ABBV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.20 per share, and an increase next year of $1.21 per share.
Genmab AS Earnings Growth & GNMSF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
AbbVie Technical Analysis
Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Genmab AS Technical Analysis
Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |